retatrutide peptide 10 mg (RETA) – Research Retatrutide - Alignpeptides

In participants without type 2 diabetes, the highest doses (8 mg and 12 mg) were associated with mean reductions in body weight of approximately 17% at 24 weeks

The 2026 Buyers Guide The compounded GLP-1 market grew from a niche workaround during the 20222024 brand drug shortages into a multi-billion dollar telehealth segment

So I think it is very, very promising, but I would not, as an oncologist, consider the data at this point definitive

Some users report receiving damaged medication or being charged without receiving shipments

[DOI] [PMC free article] [PubMed] [Google Scholar] 55.Yang G, et al

In a study comparing tirzepatide and semaglutide, tirzepatide reduced HbA1c by 2.01% to 2.30%, depending on the dose, while semaglutide reduced it by 1.86% in 40 weeks 13